Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001628280-20-016415
Filing Date
2020-11-13
Accepted
2020-11-13 16:02:50
Documents
27

Document Format Files

Seq Description Document Type Size
1 424B4 keros424followonnovember.htm 424B4 3049131
2 business10c1a.jpg GRAPHIC 1132300
3 business11d1a.jpg GRAPHIC 500448
4 business12b1a.jpg GRAPHIC 21642
5 business13c1a.jpg GRAPHIC 419413
6 business14e1a.jpg GRAPHIC 335870
7 business15c1a.jpg GRAPHIC 15062
8 business16b1a.jpg GRAPHIC 26160
9 business17d1a.jpg GRAPHIC 5005973
10 business18b1a.jpg GRAPHIC 521784
11 business19b1a.jpg GRAPHIC 41190
12 business20c1a.jpg GRAPHIC 684807
13 business21c1a.jpg GRAPHIC 1881615
14 business22e1a.jpg GRAPHIC 1236301
15 business23b1a.jpg GRAPHIC 645028
16 business24b11a.jpg GRAPHIC 51441
17 business25b1a.jpg GRAPHIC 73343
18 business2b1a.jpg GRAPHIC 249520
19 business3d1a.jpg GRAPHIC 69632
20 business4b1a.jpg GRAPHIC 238848
21 business5b1a.jpg GRAPHIC 197640
22 business6d1a.jpg GRAPHIC 1096110
23 business7c1a.jpg GRAPHIC 1914676
24 business8b1a.jpg GRAPHIC 1655832
25 business9c1a.jpg GRAPHIC 1251532
26 keroslogo1a11a.jpg GRAPHIC 8543
27 prospectussummary1c2a.jpg GRAPHIC 284192
  Complete submission text file 0001628280-20-016415.txt   29025570
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-250010 | Film No.: 201311399
SIC: 2834 Pharmaceutical Preparations